NASDAQ-NMS:QDEL

Powerful Lyme Disease Awareness PSA Featuring Christopher Meloni Illuminates Times Square

Retrieved on: 
Tuesday, October 17, 2023
Lyme disease, Social media, PSA, Heart, Hope, Family, Chronic Lyme disease, Times Square, Judgement, GLA, Dream, Partnership, Tick-Borne Disease Alliance, QuidelOrtho, Poultry farming

STAMFORD, Conn., Oct. 17, 2023 /PRNewswire/ -- In an inspiring and emotional display of solidarity for Lyme disease awareness, a striking public service announcement (PSA) has taken center stage in the heart of New York City's Times Square. The PSA, is a poignant call to action, shedding light on chronic Lyme disease.

Key Points: 
  • The PSA, is a poignant call to action, shedding light on chronic Lyme disease.
  • Directed by Erich Bergen, the PSA features Global Lyme Alliance (GLA) celebrity ambassador and actor Christopher Meloni, whose family has been impacted by Lyme disease.
  • The decision to feature the PSA in Times Square reflects a collective effort to bring awareness to chronic Lyme disease.
  • "We hope this PSA will serve as a tool to bring awareness to the often underestimated magnitude of Lyme disease.

ImageMover and QuidelOrtho Partner to Simplify Test-to-Treat Process for Pharmacies

Retrieved on: 
Monday, February 27, 2023
Point-of-care testing, Pharmacy, RSV, Hospital, Partnership, Virus, Marketing, Patient, QuidelOrtho, Health, ImageMovers, Lyme disease, Workflow, Pharmacist, COVID-19, Vaccine, Nursing, Health care

This revolutionary combination of diagnostic hardware and customized software offers patients fast and accurate results and simplifies the test-to-treat process for pharmacists.

Key Points: 
  • This revolutionary combination of diagnostic hardware and customized software offers patients fast and accurate results and simplifies the test-to-treat process for pharmacists.
  • With this patient-friendly system, pharmacies can onboard patients 80% faster than with the current manual process and are freed up to focus on what really matters – delivering the best possible patient care.
  • The small instrument size and room-temperature storage of kits make the test suitable for pharmacies, hospitals, urgent care centers, and physician offices.
  • "With QuidelOrtho tests and Workflow Services, pharmacies can confidently expand their care delivery methods with reliable tests and simple workflows."

ORTHO RANKS NO. 1 IN CUSTOMER SATISFACTION FOR 5 YEARS IN A ROW

Retrieved on: 
Tuesday, July 26, 2022
Knowledge, Immunoassay, Transfusion medicine, Customer integrated system, Quidel Corporation, Partnership, Informatics, IMV, IVD, Technology, Nasdaq, Ortho Clinical Diagnostics, Science, Automation, Management, Medicine, Medical device, Ortho

SAN DIEGO, July 26, 2022 /PRNewswire/ -- QuidelOrtho Corporation (NASDAQ: QDEL) ("QuidelOrtho") announced today that its subsidiary, Ortho Clinical Diagnostics, a leading provider of in vitro diagnostics solutions and services to hospitals, clinical laboratories and blood banks around the world, has earned the No. 1 ranking in the diagnostics industry for Overall Customer Satisfaction in the 2022 IMV ServiceTrak™ Awards for the fifth consecutive year. The ranking is based on interviews conducted with laboratory professionals, including Ortho's customers, from more than 1,200 clinical testing locations operating over 1,900 collective instruments.   The prestigious annual IMV ServiceTrak™ Awards rankings affirm the continued power and impact of Ortho's innovative Ortho Care® Services and Informatics platform.

Key Points: 
  • Because of Ortho's culture of customer focus, the entire organization rallied to support customers during a difficult year."
  • Ortho Care Services and Informatics is the evolution of how service, expertise, technology and data-driven solutions come together to create a more effective, efficient lab, so labs can focus on improving patient outcomes.
  • The total offering consists of Ortho Care Intel, Ortho Care Ops, and Ortho Care Teams.
  • For more information about Ortho's award-winning Ortho Care Services and Informatics program, visit the Ortho Care Services and Informatics home page on Ortho's U.S. website or contact Ortho here .

ORTHO RANKS NO. 1 IN CUSTOMER SATISFACTION FOR 5 YEARS IN A ROW

Retrieved on: 
Tuesday, July 26, 2022
Knowledge, Immunoassay, Transfusion medicine, Customer integrated system, Quidel Corporation, Partnership, Informatics, IMV, IVD, Technology, Nasdaq, Ortho Clinical Diagnostics, Science, Automation, Management, Medicine, Medical device, Ortho

SAN DIEGO, July 26, 2022 /PRNewswire/ -- QuidelOrtho Corporation (NASDAQ: QDEL) ("QuidelOrtho") announced today that its subsidiary, Ortho Clinical Diagnostics, a leading provider of in vitro diagnostics solutions and services to hospitals, clinical laboratories and blood banks around the world, has earned the No. 1 ranking in the diagnostics industry for Overall Customer Satisfaction in the 2022 IMV ServiceTrak™ Awards for the fifth consecutive year. The ranking is based on interviews conducted with laboratory professionals, including Ortho's customers, from more than 1,200 clinical testing locations operating over 1,900 collective instruments.   The prestigious annual IMV ServiceTrak™ Awards rankings affirm the continued power and impact of Ortho's innovative Ortho Care® Services and Informatics platform.

Key Points: 
  • Because of Ortho's culture of customer focus, the entire organization rallied to support customers during a difficult year."
  • Ortho Care Services and Informatics is the evolution of how service, expertise, technology and data-driven solutions come together to create a more effective, efficient lab, so labs can focus on improving patient outcomes.
  • The total offering consists of Ortho Care Intel, Ortho Care Ops, and Ortho Care Teams.
  • For more information about Ortho's award-winning Ortho Care Services and Informatics program, visit the Ortho Care Services and Informatics home page on Ortho's U.S. website or contact Ortho here .